Topics

"Novartis Reports Positive Results From Ofatumumab Phase Studies" Drugs and Medication Database

01:14 EST 12th November 2019 | BioPortfolio

Here are the most relevant "Novartis Reports Positive Results From Ofatumumab Phase Studies" Drugs and Medications that we have found in our database.

More Information about "Novartis Reports Positive Results From Ofatumumab Phase Studies" on BioPortfolio

We have published hundreds of Novartis Reports Positive Results From Ofatumumab Phase Studies news stories on BioPortfolio along with dozens of Novartis Reports Positive Results From Ofatumumab Phase Studies Clinical Trials and PubMed Articles about Novartis Reports Positive Results From Ofatumumab Phase Studies for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Novartis Reports Positive Results From Ofatumumab Phase Studies Companies in our database. You can also find out about relevant Novartis Reports Positive Results From Ofatumumab Phase Studies Drugs and Medications on this site too.

Showing "Novartis Reports Positive Results From Ofatumumab Phase Studies" Drugs and Medications 1–25 of 36

Possibly Relevant

Arzerra [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA. ARZERRA (ofatumumab) injection, for intravenous useInitial U.S. Approval: 2009

Bss [alcon laboratories, inc.]

BSS Sterile Irrigating Solution (balanced salt solution)

Bss [alcon laboratories, inc.]

BSS Sterile Irrigating Solution(balanced salt solution)

Bss [alcon laboratories, inc.]

BSS Sterile Irrigating Solution (balanced salt solution)

Tetracaine hydrochloride [alcon laboratories, inc.]

These highlights do not include all the information needed to use Tetracaine Hydrochloride Ophthalmic Solution 0.5% STERI‑UNITsafely and effectively. See full prescribing information for Tetracaine Hydrochloride Ophthalmic Solution. Tetracaine Hydrochlo

Bss plus [alcon laboratories, inc.]

BSS PLUS STERILE IRRIGATING SOLUTION(balanced salt solution enriched with bicarbonate, dextrose, and glutathione)

Imbruvica [pharmacyclics llc]

These highlights do not include all the information needed to use IMBRUVICA safely and effectively. See full prescribing information for IMBRUVICA. IMBRUVICA (ibrutinib) capsules, for oral useIMBRUVICA (ibrutinib) tablets, for oral useInitial U.S. Approva

Bss plus [alcon laboratories, inc.]

BSS PLUS STERILE INTRAOCULAR IRRIGATING SOLUTION(balanced salt solution enriched with bicarbonate, dextrose, and glutathione)

Myfortic [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use MYFORTIC safely and effectively. See full prescribing information for MYFORTIC. MYFORTIC® (mycophenolic acid) delayed-release tablets, for oral use Initial U.S. Approval: 2004

Cyclogyl [alcon laboratories, inc.]

CYCLOGYL (cyclopentolate hydrochloride ophthalmic solution, USP)

Copiktra [verastem, inc.]

These highlights do not include all the information needed to use COPIKTRA safely and effectively. See full prescribing information for COPIKTRA. COPIKTRA (duvelisib), capsules for oral use Initial U.S. Approval: 2018

Isopto atropine [alcon laboratories, inc.]

These highlights do not include all the information needed to use ISOPTO® ATROPINE safely and effectively. See full prescribing information for ISOPTO® ATROPINE ISOPTO® ATROPINE (atropine sulfate ophthalmic solution) 1%, for topical  ophthalmic useIni

Betadine [alcon laboratories, inc.]

BETADINE* 5% Sterile Ophthalmic Prep Solution (povidone-iodine ophthalmic solution)(0.5% available iodine)

Cyclomydril [alcon laboratories, inc.]

Cyclomydril (cyclopentolate hydrochloride and phenylephrine hydrochloride ophthalmic solution) Sterile

Femara [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use FEMARA safely and effectively. See full prescribing information for FEMARA. Femara (letrozole) tablets, for oral use Initial U.S. Approval: 1997

Tobi podhaler [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use TOBI Podhaler safely and effectively. See full prescribing information for TOBI Podhaler. TOBI PODHALER™ (tobramycin inhalation powder), for oral inhalation use Initial U.S. Approval: 197

Miostat [alcon laboratories, inc.]

MIOSTAT*      (CARBACHOL INTRAOCULAR SOLUTION, USP) 0.01%

Maxidex [alcon laboratories, inc.]

Maxidex (dexamethasone ophthalmic suspension) 0.1% Sterile

Natacyn [alcon laboratories, inc.]

NATACYN (natamycin ophthalmic suspension) 5% Sterile

Entresto [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use ENTRESTO safely and effectively. See full prescribing information for ENTRESTO. ENTRESTO (sacubitril and valsartan) tablets, for oral use Initial U.S. Approval: 2015

Patanol [alcon laboratories, inc.]

PATANOL (olopatadine hydrochloride ophthalmic solution) 0.1%

Pazeo [alcon laboratories, inc.]

These highlights do not include all the information needed to use PAZEO safely and effectively.  See full prescribing information for PAZEO. PAZEO (olopatadine hydrochloride ophthalmic solution) 0.7% For topical ophthalmic administration. Initial U.S. Ap

Emadine [alcon laboratories, inc.]

EMADINE (emedastine difumarate ophthalmic solution) 0.05%

Iclusig [millennium pharmaceuticals, inc.]

These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG(ponatinib) tablets, for oral use Initial U.S. Approval: 2012

Flarex [alcon laboratories, inc.]

Flarex (fluorometholone acetate ophthalmic suspension) 0.1%Sterile



Quick Search